Safety and effectiveness of omalizumab for the treatment of chronic urticaria in pediatric patients

BACKGROUND: Evidence on safety and effectiveness of omalizumab for treatment of chronic urticaria in pediatric patients is scarce and limited to case reports. In particular, drug survival of omalizumab has not yet been investigated, which is a key element in the evaluation of its clinical performanc...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Pediatr Allergy Immunol
Autores principales: Dekkers, Coco, Alizadeh Aghdam, Mehran, de Graaf, Marlies, Knulst, André C., Meijer, Yolanda, van den Reek, Juul M. P.A., Stadermann, Marike B., Röckmann, Heike
Formato: Artigo
Lenguaje:Inglês
Publicado: John Wiley and Sons Inc. 2021
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8248194/
https://ncbi.nlm.nih.gov/pubmed/33305439
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/pai.13426
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares